Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation

Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation

Background: Nonselective beta-blockers (NSBBs) can reduce the incidence or mortality of certain types of cancers, and NSBBs exert a protective effect on hepatocellular carcinoma (HCC) in patients with cirrhosis. However, the potential preventive effect of NSBBs has not yet been investigated in patie...

Full description

Bibliographic Details
Main Authors: He-Yun Cheng, Hsiu C. Lin, Hsiu L. Lin, Yow S. Uang, Joseph J. Keller, Li H. Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Pharmacology
Subjects:
nonselective beta-blockers
hepatocellular carcinoma
chronic hepatitis B
hepatitis B infection
propranolol
carvedilol
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.805318/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.805318/full

Similar Items